MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ben Creelan, MD
Moffit Cancer Center
Principal Investigator - Don Gibbons, MD
M.D. Anderson Cancer Center
Principal Investigator - Dong-Wan Kim, MD
Seoul National University Hospital
Principal Investigator - Laura Chow, MD
University of Washington
Principal Investigator - Naoyuki Nogami
Shikoku Cancer Center
Principal Investigator - Sang-We Kim, MD
Asan Medical Center
Principal Investigator - Shinitaro Kanda, MD
National Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Chūōku, Japan
- Research Site
Matsuyama, Japan
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Tampa, Florida, United States
- Research Site
Houston, Texas, United States
- Research Site
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Mar 2014
- Primary completion
- 9 Mar 2021
- Completion
- 9 Mar 2021
- Last update posted
- 4 Apr 2022
- Registered enrollment
- 56
- Registry id
- NCT02088112
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.